BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 778323)

  • 21. A non-T, non-B human leukemia cell line (NALM-1): establishment of the cell line and presence of leukemia-associated antigens.
    Minowada J; Tsubota T; Greaves MF; Walters TR
    J Natl Cancer Inst; 1977 Jul; 59(1):83-7. PubMed ID: 301573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of xenoantiserum produced against B cell acute lymphoblastic leukemia cell line.
    Akagi T; Sonobe H; Miyoshi I; Yoshimoto S
    Acta Med Okayama; 1982 Oct; 36(5):325-30. PubMed ID: 6184955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T and B lymphocyte antigen-positive null cell leukemias.
    Kaplan J; Ravindranath Y; Peterson WD
    Blood; 1977 Mar; 49(3):371-8. PubMed ID: 65190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen heterogeneity of human B and T lymphocytes.
    Rabellino EM; Grey HM; LaForge S; Pirofsky B; Kashiwagi N; Malley A
    J Clin Invest; 1976 Feb; 57(2):390-7. PubMed ID: 815274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human leukemia antigen. I. Production and characterization of antisera.
    Billing R; Terasaki PI
    J Natl Cancer Inst; 1974 Dec; 53(6):1635-8. PubMed ID: 4612163
    [No Abstract]   [Full Text] [Related]  

  • 26. Human leukaemia-associated antigens expressed by acute myelocytic leukaemia cells and their detection by heterologous antisera.
    Thränhardt H; Milleck J; Zintl F; Koppitz D; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(3):311-20. PubMed ID: 89982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surface markers for T and B lymphocytes in normals and patients with lymphoproliferative disorders.
    Cohnen G; Augener W; Douglas SD; König E; Brittinger G
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:295. PubMed ID: 4605188
    [No Abstract]   [Full Text] [Related]  

  • 28. A novel human T cell antigen preferentially expressed on mature T cells and shared by both well and poorly differentiated B cell leukemias and lymphomas.
    Kamoun M; Kadin ME; Martin PJ; Nettleton J; Hansen JA
    J Immunol; 1981 Sep; 127(3):987-91. PubMed ID: 6790625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte surface characteristics in malignant lymphoma.
    Aisenberg AC; Long JC
    Am J Med; 1975 Mar; 58(3):300-6. PubMed ID: 1090157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistological analysis of human lymphoma: correlation of histological and immunological categories.
    Stein H; Lennert K; Feller AC; Mason DY
    Adv Cancer Res; 1984; 42():67-147. PubMed ID: 6395656
    [No Abstract]   [Full Text] [Related]  

  • 31. Detection and partial characterization of human T and B lymphocyte membrane antigens with antisera to HSB and SB cell lines.
    Anderson JK; Metzgar RS
    J Immunol; 1978 Jan; 120(1):262-71. PubMed ID: 304868
    [No Abstract]   [Full Text] [Related]  

  • 32. Examinations of the bactericidal properties of the serum against gram-positive microbes in patients suffering from leukaemia, malignant lymphoma, myeloma and myelofibrosis.
    Libánský J; Jezková Z
    Experientia; 1964 Mar; 20(3):124-7. PubMed ID: 5322537
    [No Abstract]   [Full Text] [Related]  

  • 33. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specificity of heteroantisera to human acute leukemia-associated antigens.
    Baker MA; Ramachandar K; Taub RN
    J Clin Invest; 1974 Dec; 54(6):1273-8. PubMed ID: 4140196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of human B-lymphocyte antigens by most lymphocytic and myelocytic leukemia cells.
    Billing RJ; Ting A; Terasaki PI
    Transplant Proc; 1977 Mar; 9(1):1145-7. PubMed ID: 68565
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunoglobulin composition of the blood in hemolymphoblastosis].
    Medina F; Tognella S
    Folia Allergol (Roma); 1967; 14(6):447-52. PubMed ID: 4171226
    [No Abstract]   [Full Text] [Related]  

  • 37. HLA antigens on human peripheral lymphocytes and spleen of malignant lymphoma and other cancer patients.
    Cohen E; Kim U; Blumenson L; Gregory SG; Khurana U; Cox C
    Prog Clin Biol Res; 1977; 16():181-6. PubMed ID: 269456
    [No Abstract]   [Full Text] [Related]  

  • 38. A unique cell surface antigen identifying lymphoid malignancies of B cell origin.
    Nadler LM; Ritz J; Hardy R; Pesando JM; Schlossman SF; Stashenko P
    J Clin Invest; 1981 Jan; 67(1):134-40. PubMed ID: 6969730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human leukemia-associated antigens: detection on cells of established lymphoblastoid lines.
    Mohanakumar T; Pauly JL; Sokal JE; Metzgar RS
    J Immunol; 1975 Dec; 115(6):1542-8. PubMed ID: 171308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired immunoresponsiveness in tumor patients.
    Harris J; Copeland D
    Ann N Y Acad Sci; 1974; 230():56-85. PubMed ID: 4595955
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.